In conclusion, the results of this study on BMDMs and ApoE−/− mice suggest that DHC reduces atherosclerosis and inflammation by inhibiting the activation of p65 and ERK1/2, and the natural product DHC may be a potential drug to treat atherosclerosis and its associated sterile inflammation. The gene discussed is MAPK3; the disease is atherosclerosis.